BSX · Boston Scientific Corp · Executive Compensation

$44.34 +0.14 (+0.32%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$64.27B

1.45B

Volume · Nov 13 9.7M Avg daily vol (3M) 19.61M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,442,603	—	$13,608,056	$3,749,980	$4,002,001	$287,799	$23,532,050
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiovascular	$892,604	—	$4,309,282	$1,187,463	$1,458,001	$45,657	$8,042,997
Arthur C. Butcher	Executive Vice President and Group President, MedSurg and Asia Pacific	$744,822	—	$3,447,272	$949,962	$1,012,501	$219,667	$6,534,719
Daniel Brennan	Former Executive Vice President and Chief Financial Officer	$660,990	—	$3,447,272	$949,962	$1,098,004	$36,738	$6,282,896
Jonathan Monson	Executive Vice President and Chief Financial Officer	$591,848	—	$1,624,898	$1,170,504	$840,000	$38,453	$6,083,679
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$702,042	—	$1,995,566	$549,989	$793,126	$59,238	$4,159,959
Vance R. Brown	Senior Vice President, General Counsel and Corporate Secretary	$659,086	—	$1,723,636	$474,960	$897,751	$45,286	$3,920,644

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,400,000	—	$12,229,998	$3,562,493	$3,743,250	$193,394	$21,420,801
Daniel Brennan	Executive Vice President and Chief Financial Officer	$843,146	—	$3,261,199	$949,983	$1,472,667	$25,148	$6,687,005
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$842,360	—	$3,089,627	$899,991	$1,319,632	$34,317	$6,335,804
Arthur C. Butcher	Executive Vice President and Group President, MedSurg and Asia Pacific	$708,884	—	$2,402,895	$699,995	$957,206	$39,036	$5,013,447
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$680,411	—	$1,887,957	$549,993	$770,627	$48,092	$4,027,076

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,400,000	—	$10,472,753	$3,124,984	$3,244,150	$190,181	$18,723,735
Daniel Brennan	Executive Vice President and Chief Financial Officer	$801,528	—	$2,764,794	$825,000	$1,323,938	$23,677	$5,829,147
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$793,560	—	$2,764,794	$825,000	$1,016,657	$27,372	$5,592,519
Arthur C. Butcher	Executive Vice President and Group President, MedSurg and Asia Pacific	$672,077	—	$2,010,731	$599,998	$756,872	$62,299	$4,273,657
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$652,646	—	$1,759,429	$524,992	$734,422	$51,498	$3,782,995

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,395,178	—	$9,924,100	$2,874,985	$2,278,500	$92,530	$16,941,961
Daniel Brennan	Executive Vice President and Chief Financial Officer	$765,959	—	$2,588,909	$749,991	$900,240	$22,106	$5,252,206
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$740,178	—	$2,416,234	$699,996	$764,649	$23,529	$4,764,586
Arthur C. Butcher	Executive Vice President and Group President, MedSurg and Asia Pacific	$634,329	—	$1,903,298	$799,984	$471,120	$295,401	$4,173,434
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$631,986	—	$1,812,175	$524,989	$482,251	$35,843	$3,562,244

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,344,329	—	$9,126,292	$2,749,999	$2,346,000	$137,419	$16,064,039
Daniel Brennan	Executive Vice President and Chief Financial Officer	$692,183	—	$2,281,542	$687,497	$684,250	$24,496	$4,429,827
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$699,130	—	$2,074,084	$624,999	$843,180	$23,191	$4,309,535
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$598,249	—	$1,659,292	$499,992	$573,546	$35,085	$3,456,145

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$666,878	—	$8,395,367	$2,749,991	$1,485,000	$76,873	$13,773,795
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$568,679	—	$1,907,997	$1,624,991	$414,010	$22,754	$4,598,333
Daniel Brennan	Executive Vice President and Chief Financial Officer	$560,422	—	$1,907,997	$624,992	$455,206	$21,204	$3,668,993
Edward F. Mackey	Executive Vice President, Operations	$497,670	—	$2,144,740	$374,991	$391,374	$20,692	$3,599,526
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$495,001	—	$1,450,047	$474,996	$350,179	$30,563	$2,956,196

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,274,740	—	$9,087,249	$2,699,992	$1,996,800	$296,069	$15,764,140
Daniel Brennan	Executive Vice President and Chief Financial Officer	$655,437	—	$1,977,244	$587,497	$583,482	$37,241	$4,031,286
Joseph M. Fitzgerald	Executive Vice President and President, Interventional Cardiology	$667,416	—	$2,103,497	$624,989	$546,760	$22,732	$4,025,457
Kevin J. Ballinger	Executive Vice President and President, Interventional Cardiology	$587,382	—	$1,598,620	$474,995	$460,205	$20,013	$3,368,572
Edward F. Mackey	Executive Vice President, Operations	$577,398	—	$1,472,367	$437,491	$520,282	$34,851	$3,198,962

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,234,630	—	$7,643,884	$2,499,993	$2,128,770	$151,692	$13,970,901
Joseph M. Fitzgerald	Executive Vice President and President, Interventional Cardiology	$639,958	—	$1,910,971	$624,994	$582,425	$32,636	$4,036,318
Daniel Brennan	Executive Vice President and Chief Financial Officer	$621,637	—	$1,719,882	$562,495	$626,736	$33,058	$3,665,825
Kevin J. Ballinger	Executive Vice President and President, Interventional Cardiology	$567,362	—	$1,337,622	$437,498	$448,918	$45,571	$2,841,486

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,179,452	—	$7,225,607	$2,249,995	$1,890,000	$122,254	$13,084,452
Joseph M. Fitzgerald	Executive Vice President and President, Rhythm Management	$564,740	—	$1,435,716	$2,949,992	$595,139	$19,641	$5,838,997
Daniel Brennan	Executive Vice President and Chief Financial Officer	$593,194	—	$1,766,253	$549,994	$504,037	$21,141	$3,632,769
Kevin J. Ballinger	Executive Vice President and President, Interventional Cardiology	$543,151	—	$1,316,086	$412,493	$346,500	$18,963	$2,808,571

Executive changes

Person	Role	Change	Effective	Filed
Mark Bickel	Senior Vice President, Global Accounting Controller and Chief Accounting Officer	Appointed	2027-03-01	2026-10-07
Joe Fitzgerald	Executive Vice President and Chief Operating Officer	Appointed	2027-01-01	2026-10-07
Arthur C. Butcher	Executive Vice President and Group President, MedSurg and Asia Pacific	Retired	2027-01-01	2026-09-23
Christophe P. Weber	director of the Company	Appointed	2026-02-18	2026-02-23
Catherine R. Smith	director of the Company	Appointed	2026-02-18	2026-02-23
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	Retired	2025-12-01	2025-09-04
Jonathan Monson	Executive Vice President and Chief Financial Officer	Appointed	2025-06-30	2025-04-23
Daniel J. Brennan	Executive Vice President and Chief Financial Officer	Retired	2025-06-29	2025-04-23
David C. Habiger	director	Appointed	2024-07-30	2024-07-30
Dr. Cheryl Pegus	board of directors	Appointed	2024-05-08	2024-05-10
Cheryl Pegus	director of the Company	Appointed	2024-05-08	2024-05-10
Jonathan Monson	Senior Vice President, Investor Relations	Appointed	2024-03-01	2024-01-31
Emily Woodworth (Collins)	Senior Vice President, Global Controller and Chief Accounting Officer	Appointed	2024-03-01	2024-01-31
Susan E. Morano	director	Appointed	2023-06-27	2023-06-27
Jessica L. Mega, MD, MPH	director	Appointed	2023-06-27	2023-06-27

Leadership

Michael Mahoney CEO
Jonathan Monson CFO
Joe Fitzgerald COO
Jodi Euerle Eddy CIO
Desiree Ralls-Morrison General Counsel
Vance R. Brown General Counsel
Emily Woodworth (Collins) Chief Accounting Officer
Mark Bickel Chief Accounting Officer
Catherine R. Smith Board Member
Cheryl Pegus Board Member
Cheryl Pegus, MD, MPH Board Member
Christophe P. Weber Board Member
David C. Habiger Board Member
David S. Wichmann Board Member
Dr. Cheryl Pegus Board Member
Jessica L. Mega Board Member
Jessica L. Mega, MD, MPH Board Member
Susan E. Morano Board Member

Key facts CIK 885725 CUSIP 101137107 13F (30d) 1217 filings 1128 filers Visit website Investor relations